Apparently the IPO filing hiatus isn’t entirely a dead end story. A company called AutoGenomics, Inc. has filed a registration statement for a proposed initial public offering. It has applied for the ticker "AGMX" on NASDAQ.
The share count and the pricing of this IPO are not yet determined, but it listed the "up to"amount as $86.3 million for filing purposes. All shares in the offering will be sold by the company rather than insiders.
The company lists J.P. Morgan Securities as the sole book-runner andalso lists Deutsche Bank Securities as co-lead manager. Co-managersare listed as Pacific Growth Equities and Robert W. Baird & Co.
The company designs, develops, manufactures and markets a fullyintegrated molecular diagnostics system called the INFINITI™ thatautomates the discrete processes of genetic testing performed byclinical laboratories. It already holds trademarks of INFINITI™,BioFilmChip™, Intellipac™ and Qmatic™, and it received market approvalfrom the FDA for its INFINITI™ system.
Jon C. Ogg
July 25, 2008
Take This Retirement Quiz To Get Matched With An Advisor Now (Sponsored)
Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it could be a good idea to speak to a fiduciary financial advisor about your goals today.
Start by taking this retirement quiz right here from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes. Smart Asset is now matching over 50,000 people a month.
Click here now to get started.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
